Bettina Maunz
Plus aucun poste en cours
Profil
Bettina Maunz served as Chief People Officer & Head-Communications at Graybug Vision, Inc. and Vice President & Global Head-Communications at Ciba Vision Corp.
She also held the position of Head-Communications at Novartis Pharmaceuticals Corp.
and was the President of Alcon Foundation, Inc. Additionally, she served as VP & Global Head-Communications at Alcon Pharmaceuticals Cham.
Prior to her career in the pharmaceutical industry, she was a Trustee at Helen Keller International.
Maunz received an undergraduate degree from Mannheim Business School gGmbH.
Anciens postes connus de Bettina Maunz
| Sociétés | Poste | Fin |
|---|---|---|
| Alcon Foundation, Inc. | President | - |
| Alcon Pharmaceuticals Cham | Public Communications Contact | - |
| CALCIMEDICA, INC. | Public Communications Contact | - |
Helen Keller International
 Helen Keller International Miscellaneous Commercial ServicesCommercial Services Helen Keller International provides social services. It builds local capacity to combat blindness and malnutrition by establishing sustainable programs. The firm also provides scientific technical assistance, as well as research and data, to governments and international, regional, national, and local organizations to help expand current approaches and develop new ones. The company was founded by Helen Keller in 1915 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Public Communications Contact | - |
Formation de Bettina Maunz
| Mannheim Business School gGmbH | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Ciba Vision Corp.
 Ciba Vision Corp. Electronic ComponentsElectronic Technology CIBA VISION Corp. manufactures eyeglasses, contact lenses and lens care products. It offers research, development, manufacturing contact lenses and lens care products. The company was founded in 1980 and is headquartered in Duluth, GA. | Electronic Technology |
Helen Keller International
Helen Keller International Miscellaneous Commercial ServicesCommercial Services Helen Keller International provides social services. It builds local capacity to combat blindness and malnutrition by establishing sustainable programs. The firm also provides scientific technical assistance, as well as research and data, to governments and international, regional, national, and local organizations to help expand current approaches and develop new ones. The company was founded by Helen Keller in 1915 and is headquartered in New York, NY. | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Alcon Foundation, Inc. | |
| Alcon Pharmaceuticals Cham |
